$15.45
arrow_drop_up4.37%Key Stats | |
---|---|
Open | $14.71 |
Prev. Close | $14.86 |
EPS | 119.39 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $223.65M |
LOW | HIGH | |
---|---|---|
Day Range | 14.59 | 15.57 |
52 Week Range | 10.80 | 39.79 |
Ratios | |
---|---|
EPS | 119.39 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Inhibrx stock rated 'Market Perform' by JMP after Sanofi acquisition - Investing.com
Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates
BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings and Revenue Estimates
Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY Inks M&A Deal With INBX
Biotech Stock Roundup: GILD Down on Study Results, INBX Gains on Sanofi Deal & More
Inhibrx, Inc. (INBX) Soars 8.9%: Is Further Upside Left in the Stock?